Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Applovin Corporation (APP) vs Centene Corp (CNC) Price & Performance

Applovin CorporationTrade
Centene CorpTrade

Price performance (Past 24H)

Key statistics

Applovin Corporation vs Centene Corp — how do they compare? Applovin Corporation trades at $484.48 (market cap $170.31B), while Centene Corp trades at $68.53 (market cap $33.26B). The key difference: Applovin Corporation is far larger — about 5.1× Centene Corp's market cap, and Centene Corp is trading nearer its 52-week high, Applovin Corporation nearer its low. Which is the better fit depends on your goals.

APPCNC
Market Cap
$170.31B$33.26B
Sector
TechnologyHealth
52-Week High
$733.60$68.34
52-Week Low
$335.10$25.21
Enterprise Value
$171.07B$25.89B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Applovin Corporation

AppLovin trades at $506.98, down 2.58% today, with a bullish technical setup near pivot point support at $504. The company shows exceptional fundamentals with 59% revenue growth in Q1 2026 and net margins exceeding 64%. Analyst consensus remains strongly bullish with an $644.09 price target, supported by expanding e-commerce advertising share and AI-driven platform growth noted in recent Jefferies research.

The outlook remains positive given consistent earnings beats and projected revenue growth to $6.2B in 2026. Primary risks include premium valuation multiples (P/E 44.09) and competitive pressure in mobile advertising. The stock offers growth exposure but requires monitoring of execution against high expectations.

Centene Corp

Centene (CNC) trades at $67.35, down 0.37% on the day, with a bullish technical signal from moving averages. The stock shows attractive valuation ratios, including a P/E of 8.06 and P/S of 0.17, but faces profitability challenges with a negative net income margin of -3.25% for 2025. Recent positive developments include the renewal of a key Illinois Medicaid contract and consistent earnings beats in recent quarters, supporting a strong analyst consensus with 61% buy ratings.

The outlook for CNC hinges on successful margin recovery initiatives and cost management. Investment opportunities lie in its undervalued metrics and stable revenue base, but risks include persistent negative profitability, regulatory pressures in healthcare, and execution challenges in improving medical cost controls. The consensus price target of $63.36 suggests limited near-term upside from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Applovin Corporation

AppLovin provides a software platform for mobile app developers to market, monetize, and analyze their apps. Its AI-powered tools help developers grow their business by connecting them with global advertising networks.

Read more on APP

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC